Summary
bioMerieux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
bioMerieux SA (bioMerieux or 'the company'), is a provider of diagnostic solutions for medical and industrial applications. These products are used to diagnose cardiovascular diseases, targeted cancers and infectious diseases and provides various vitro diagnostic solutions for hospitals. bioMerieux also offers sterility and quality testings for cosmetics, pharmaceutical and food sectors. The company also offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical and cosmetics industries; and veterinary diagnostic laboratories. It has operations across Europe, the Middle East and Africa, the Americas and Asia-Pacific. The company is headquartered in Marcy l'Etoile, Rhone Alpes, France.
Scope
- Detailed information on bioMerieux SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting bioMerieux SA in the form of a SWOT analysis
- An in-depth view of the business model of bioMerieux SA including a breakdown and examination of key business segments
- Intelligence on bioMerieux SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about bioMerieux SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of bioMerieux SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess bioMerieux SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on bioMerieux SA's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
bioMerieux SA.: Company Overview
bioMerieux SA.: Overview and Key Facts
bioMerieux SA.: Overview
bioMerieux SA.: Key Facts
bioMerieux SA.: Key Employees
bioMerieux SA.: Key Employee Biographies
bioMerieux SA.: Major Products and Services
bioMerieux SA.: Company History
bioMerieux SA.: Management Statement
bioMerieux SA.: Locations and Subsidiaries
bioMerieux SA.: Key Competitors
bioMerieux SA.: Company Analysis
bioMerieux SA.: Business Description
bioMerieux SA.: SWOT Analysis
bioMerieux SA.: SWOT Overview
bioMerieux SA.: Strengths
bioMerieux SA.: Weaknesses
bioMerieux SA.: Opportunities
bioMerieux SA.: Threats
bioMerieux SA.: Corporate Financial Deals Activity
bioMerieux SA.: Financial Deals Overview
bioMerieux SA.: Targets and Partners
bioMerieux SA.: Top Deals 2018 - 2022YTD*
bioMerieux SA.: Advisors
bioMerieux SA.: Top Legal Advisors
bioMerieux SA.: Top Financial Advisors
bioMerieux SA.: Mergers and Acquisitions
bioMerieux SA.: Capital Raising
bioMerieux SA.: Partnership
bioMerieux SA.: Recent Developments
bioMerieux SA.: News and Events Summary
bioMerieux SA.: Contracts
bioMerieux SA.: Financial Deals
bioMerieux SA.: Financial Performance
bioMerieux SA.: Regulatory and Legal Events
bioMerieux SA.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: bioMerieux SA.: Key Facts
Table 2: bioMerieux SA.: Key Employees
Table 3: bioMerieux SA.: Company History
Table 4: bioMerieux SA.: Locations and Subsidiaries
Table 5: bioMerieux SA.: Key Competitors
Table 6: bioMerieux SA.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 7: bioMerieux SA.: M&A Average Deal Size - Value (US$m)
Table 8: bioMerieux SA.: Targets and Partners
Table 9: bioMerieux SA.: Top Deals 2018 - 2022YTD*
Table 10: bioMerieux SA.: Legal Advisor Ranking by Value (US$m)
Table 11: bioMerieux SA.: Financial Advisor Ranking by Value (US$m)
Table 12: bioMerieux SA.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 13: bioMerieux SA.: M&A Activity by Geography (2018 - YTD*2022)
Table 14: bioMerieux SA.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 15: bioMerieux SA.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 16: bioMerieux SA.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 17: bioMerieux SA.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 18: bioMerieux SA.: News and Events Summary
Table 19: bioMerieux SA.: Contracts
Table 20: bioMerieux SA.: Financial Deals
Table 21: bioMerieux SA.: Financial Performance
Table 22: bioMerieux SA.: Regulatory and Legal Events
Table 23: bioMerieux SA.: Strategy and Operations
List of Figures
Figure 1: bioMerieux SA.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 2: bioMerieux SA.: M&A Average Deal Size - Value (US$m)
Figure 3: bioMerieux SA.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 4: bioMerieux SA.: M&A Activity by Geography (2018 - YTD*2022)
Figure 5: bioMerieux SA.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 6: bioMerieux SA.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 7: bioMerieux SA.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 8: bioMerieux SA.: Partnership Trend by Deal Type (2018 - YTD*2022)
